医药合同销售组织市场基于(主要区域、市场参与者、规模和份额)- 预测至 2030 年

  • Report Code : TIPRE00030074
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 221
Buy Now

Pharmaceutical Contract Sales Organizations Market Report | Growth Forecasts to 2030

Buy Now

 

医药合同销售组织的市场规模预计将从 2022 年的 82.1202 亿美元增长到 2030 年的 158.2086 亿美元;预计 2022-2030 年期间的复合年增长率为 8.6%。

 

市场洞察和分析师观点:

制药合同销售组织与制药客户合作。正在开发的生物制剂数量的增加推动了对高科技开发和制造解决方案的需求。因此,企业正在加大对研发的投资,以创建合同智能平台,以加快严格监管的促销计划中的药物试验。新药上市数量的增加、制药研发活动的增加以及降低内部销售相关成本的需求不断增长,这些都支持了市场的增长。数字技术的日益融合和制药公司对增加产品销售的兴趣日益浓厚,是加速市场增长的关键因素。此外,远程医疗和远程细节使用的增加也推动了市场的增长。此外,合同销售组织 (CSO) 在新兴市场的扩张也加剧了制药合同销售组织市场的竞争

 

增长动力:

近年来,制药公司越来越多地采用创新策略来增加其产品的销量。这一领域中一个值得注意的趋势是,制药公司越来越依赖药品合同销售组织 (CSO) 作为其商业化努力的关键组成部分。这凸显了制药实体采取积极主动的方式来应对市场的复杂性。通过聘用 CSO,这些公司可以利用专业销售人员,利用外部能力来提高市场渗透率并优化销售业绩。这种协作模式使制药公司能够简化运营并专注于研发等核心竞争力,同时利用 CSO 的定制专业知识来增强其产品的市场占有率。制药公司和 CSO 之间日益增强的协同作用反映了对资源优化的细致理解,表明了对适应性的承诺以及对激烈竞争的制药领域中不断变化的动态的敏锐认识。这种共生关系有助于实现收入最大化,并使制药企业在敏捷性和有针对性的市场战略对于持续成功至关重要的环境中具有战略地位。因此,制药公司对增加产品销售的兴趣日益浓厚,促进了医药合同销售组织的发展。  

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

医药合同销售组织市场:

Pharmaceutical Contract Sales Organizations Market: Strategic Insights

Pharmaceutical Contract Sales Organizations Market

  • CAGR (2022 - 2030)
    8.6%
  • Market Size 2022
    US$ 8.21 Billion
  • Market Size 2030
    US$ 15.82 Billion

Market Dynamics

GROWTH DRIVERS
  • 数字技术日益融合
  • 制药公司对增加产品销售的兴趣日益浓厚
FUTURE TRENDS
  • 新兴市场的扩张
OPPORTUNITIES
  • 远程医疗和远程护理的使用日益增多

Key Players

  • CMIC Holdings Co., Ltd.
  • Axxelus
  • EPS Holdings, Inc.
  • MaBico
  • IQVIA, Inc.
  • Peak Pharma
  • QFR Solutions
  • Promoveo Health
  • Syneous Health Inc.

Regional Overview

  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

服务业(商业服务业和非商业服务业)
    模块(联合模块和专用模块)
      治疗领域(心血管疾病、肿瘤学、代谢紊乱、神经病学、骨科疾病、传染病等)
        最终用户(生物制药公司和制药公司)

          医药合同销售组织市场

          • 复合年增长率(2022 - 2030 年)
            8.6%
          • 2022 年市场规模
            82.1 亿美元
          • 2030 年市场规模
            158.2 亿美元

          市场动态

          增长动力
          • 数字技术日益融合
          • 制药公司对增加产品销量的兴趣日益浓厚
          未来的趋势
          • 新兴市场的扩张
          机会
          • 远程医疗和远程护理的使用日益增多

          关键人物;主力;重要一员

          •  
          • 华商国际控股有限公司
          • 阿克塞勒斯
          • EPS控股公司
          • 马比科
          • IQVIA 公司
          • 匹克制药公司
          • QFR 解决方案
          • Promoveo健康
          • Syneous Health Inc.

          区域概况

          • 北美
          • 欧洲
          • 亚太
          • 南美洲和中美洲
          • 中东和非洲

          市场细分

          服务
          • 商业服务和非商业服务
          模块
          • 联合模块和专用模块
          治疗领域
          • 心血管疾病
          • 肿瘤学
          • 代谢紊乱
          • 神经病学
          • 骨科疾病
          • 传染性疾病
          • 其他的
          最终用户
          • 生物制药公司和制药公司
          • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

           

          报告细分和范围:

          医药合同销售组织市场根据服务、模块、治疗领域、最终用户和地理位置进行细分。根据服务,市场分为商业服务和非商业服务。就模块而言,医药合同销售组织市场分为联合模块和专用模块。根据治疗领域,市场分为心血管疾病、肿瘤学、代谢性疾病、神经病学、骨科疾病、传染病等。就最终用户而言,医药合同销售组织市场分为生物制药公司和制药公司。根据地理区域,医药合同销售组织市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、西班牙和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。

           

          节段分析:

          医药合同销售组织市场按服务分为商业服务和非商业服务。商业服务部门在 2022 年占据了更大的市场份额,预计在 2022-2030 年期间市场复合年增长率会更高。商业服务是指 CSO 为制药公司提供的一系列服务,以支持其销售和营销工作。CSO 是专门代表制药公司提供销售和营销服务的第三方组织。这些组织提供的商业服务包括销售人员外包、市场研究和分析、医药代表培训、营销和促销支持、远程详细服务以及合规和监管支持。这些服务对于制药公司优化销售和营销策略、增强产品知识和销售技能、与关键意见领袖互动、遵守行业法规以及推动业务增长至关重要。通过将这些职能外包给 CSO,制药公司可以利用他们的专业知识、资源和灵活性,使他们能够专注于核心竞争力。

          CMIC Holdings Co., LTD 就是这样一家提供全面促销活动的 CSO,包括针对特定产品或地区的促销活动。该公司的团队制定量身定制的提案并执行理想的解决方案以满足客户要求,例如维持或扩大现有产品份额。该公司的销售代表通过面对面和远程渠道向医疗保健专业人士提供药品信息和销售信息。

          商业销售和营销在制药公司的整体收入中起着至关重要的作用。制药公司越来越多地投资于研发活动,因此商业销售和营销对制药公司的整体收入至关重要。此外,制药公司越来越有兴趣逐年增加收入,因此他们专注于推出新产品,这反过来又刺激了制药公司对这些商业服务的需求,以增加销售额。

          根据模块,医药合同销售组织市场细分为联合模块和专用模块。联合模块部分在 2022 年占据了更大的市场份额,预计在 2022-2030 年期间将以更快的速度增长。CSO 通过专用和联合模块提供服务。联合模块是指一种协作方法,多家制药公司联合起来共享资源和专业知识,以实现共同的销售和营销目标。这些模块允许公司组成一个统一的团队,推广和销售所有参与公司的产品。通过合作,联合模块可以扩大其市场范围、提高效率并降低成本,而单独运营则不行。CSO 管理联合团队,但他们推广来自不同制药公司的产品。联合模块有助于推广来自非竞争治疗领域的产品。联合模块具有提高市场渗透率、规模经济以及知识共享和创新机会等优势。联合模块已经存在很长时间了,因为公司最初为营销和促销投入了一笔总金额。总体而言,该模块为制药公司提供了一种协作方法,以加强其销售和营销力度并推动业务增长。

          联合团队也用于产品发布或抵御新竞争对手,尤其适用于季节性产品。联合团队包括销售经理和医药代表团队,他们负责不同制造商的产品,彼此之间不竞争。合同通常以四个月的可续签方式签订,标准团队由 72 名代表组成。在法国,MBO 和 CLI Innovation 等公司专注于合同销售队伍,招聘医药代表和区域经理。如今,一些公司正在寻找短期合同销售外包,并更倾向于联合模块进行产品发布,尤其是抗感染等季节性产品。

          根据治疗领域,医药合同销售组织市场细分为心血管疾病、肿瘤学、代谢性疾病、神经病学、骨科疾病、传染病等。肿瘤学领域在 2022 年占据最大的市场份额,预计在 2022-2030 年期间将实现最高复合年增长率。根据 GLOBOCAN 2020 的估计,2020 年全球报告的新癌症病例约为 1930 万例(1810 万例,不包括非黑色素瘤皮肤癌)和 1000 万例癌症死亡病例,或近六分之一的死亡病例(990 万例,不包括非黑色素瘤皮肤癌)。这增加了对用于肿瘤治疗和其他癌症治疗和疗法的药物的需求。肿瘤学是世界上发展最快的治疗领域之一,预计未来将占药品销售的很大一部分,从而对肿瘤治疗领域的医药合同销售外包的需求不断增长。

          制药公司期待在竞争激烈的市场中大规模推广其肿瘤产品,以获得整个市场的大部分份额。此外,新的创新癌症疗法的推出也促进了肿瘤领域制药合同销售组织市场的增长。这些复杂的疗法需要专业知识和专长,合同销售组织可以提供这些知识和专长,以便有效地营销和销售肿瘤药物。

          此外,个性化医疗和精准肿瘤学日益受到关注,这也为制药 CSO 带来了新机遇。这些方法需要更深入地了解患者群体及其个人治疗需求,而这可以通过制药 CSO 服务(例如市场研究和关键意见领袖 (KOL) 参与)来实现。因此,由于癌症发病率不断上升以及靶向疗法和免疫疗法等新型创新癌症治疗和疗法的不断发展,预计未来几年对肿瘤治疗领域制药 CSO 的需求将继续扩大。

          根据最终用户,医药合同销售组织市场分为生物制药公司和制药公司。制药公司部门在 2022 年占据了更大的市场份额。然而,生物制药公司部门预计将在 2022-2030 年期间以最快的速度增长。制药公司是合同销售组织 (CSO) 的主要最终用户。这些公司利用 CSO 作为战略合作伙伴来加强其销售和营销工作,简化市场准入并优化资源配置。 

          由于全球新推出的小分子药物数量不断增加,大量制药公司提供类似产品,以及公司大量采用合同销售新技术,制药公司越来越多地转向 CSO 服务。此外,招聘和留住高效的销售专业人员对制药公司来说具有挑战性;这支持了制药公司对 CSO 服务的需求。制药公司越来越多地寻求 CSO 来帮助他们快速建立强大的销售团队,降低销售团队的管理成本,节省招聘流程的时间和精力,并发展兼职合同销售团队以消除投资需求。因此,制药公司越来越注重节省金钱和时间,这为制药合同销售组织市场带来了销售机会。

           

          区域分析:

          根据地理位置,医药合同销售组织市场分为五个主要区域:北美、欧洲、亚太地区、南美和中美以及中东和非洲。北美在 2022 年占据了全球市场的很大份额。该地区的市场增长归因于合同销售组织采用新技术、制药公司强调提高小分子和生物制药药物的销售,以及更加注重削减内部销售业务产生的成本。随着时间的推移,新药的推出数量激增。根据 IQVIA 关于研发趋势的报告,2021 年全球推出了 84 种新的活性化合物,是前五年推出数量的两倍。随着国际药物发布的增加,预计对合同销售服务的需求将会增加。北美占医药合同销售组织市场的最大份额。EPS Corp.、IQVIA, Inc. 和 Axxelus 等主要参与者推动了该地区的市场增长。

           

          医药合同销售组织市场报告范围

          报告属性细节
          2022 年市场规模82.1亿美元
          2030 年的市场规模158.2亿美元
          全球复合年增长率(2022 - 2030 年)8.6%
          历史数据2020-2021
          预测期2023-2030
          涵盖的领域按服务
          • 商业服务和非商业服务
          按模块
          • 联合模块和专用模块
          按治疗领域
          • 心血管疾病
          • 肿瘤学
          • 代谢紊乱
          • 神经病学
          • 骨科疾病
          • 传染性疾病
          • 其他的
          按最终用户
          • 生物制药公司和制药公司
          覆盖地区和国家北美
          • 我们
          • 加拿大
          • 墨西哥
          欧洲
          • 英国
          • 德国
          • 法国
          • 俄罗斯
          • 意大利
          • 欧洲其他地区
          亚太
          • 中国
          • 印度
          • 日本
          • 澳大利亚
          • 亚太其他地区
          南美洲和中美洲
          • 巴西
          • 阿根廷
          • 南美洲和中美洲其他地区
          中东和非洲
          • 南非
          • 沙特阿拉伯
          • 阿联酋
          • 中东和非洲其他地区
          市场领导者和主要公司简介
          •  
          • 华商国际控股有限公司
          • 阿克塞勒斯
          • EPS控股公司
          • 马比科
          • IQVIA 公司
          • 匹克制药公司
          • QFR 解决方案
          • Promoveo健康
          • Syneous Health Inc.
          • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

           

          行业发展和未来机遇:

          以下列出了全球医药合同销售组织市场的主要参与者采取的各种举措:

          1. 2022 年 9 月,IQVIA, Inc. 与制药公司 Dr. Reddy's Laboratories 合作。根据协议,IQVIA 向 Dr. Reddy's 提供其 Orchestrated Customer Engagement (OCE) 平台的访问权限,以协助其 CRM 运营。根据合作伙伴关系,Dr. Reddy's 向其在印度的所有营销用户和现场工作人员提供了 IQVIA 的 OCE 应用程序,以便他们能够通过整合营销、客户管理、医学科学联络、销售和其他活动来更有效地吸引客户。
          2. 2021 年 7 月,ICON plc(一家为制药、生物技术、医疗设备以及政府和公共卫生公司提供外包药物和设备开发及商业化服务的全球供应商)收购了 PRA Health Sciences, Inc. 。此次合并增强了 ICON 的咨询、临床和商业服务组合、地理覆盖、治疗能力和数据驱动的医疗保健技术,旨在提供国际规模的专业知识和解决方案。

           

          竞争格局和重点公司:

          CMIC Holdings Co Ltd、Axxelus Inc、EPS Holdings Inc、MaBico SA、IQVIA Holdings Inc、Peak Pharma Solutions Inc、QFR Solutions LLC、Promoveo Health LLC、Syneos Health Inc 和 Mednext Pharmaceuticals Pvt Ltd 是顶级医药合同销售组织。这些公司专注于新技术服务、现有服务的改进和地域扩张,以满足全球日益增长的消费者需求。

          Pharmaceutical Contract Sales Organizations Market Report Scope

          Report Attribute Details
          Market size in US$ 8.21 Billion
          Market Size by US$ 15.82 Billion
          Global CAGR 8.6%
          Historical Data 2020-2021
          Forecast period 2023-2030
          Segments Covered By 服务业(商业服务业和非商业服务业)
          By 模块(联合模块和专用模块)
          By 治疗领域(心血管疾病、肿瘤学、代谢紊乱、神经病学、骨科疾病、传染病等)
          By 最终用户(生物制药公司和制药公司)
          Regions and Countries Covered 北美(美国、加拿大、墨西哥)
          • 北美(美国、加拿大、墨西哥)
          欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
          • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
          亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
          • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
          南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
          • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
          中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
          • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
          Market leaders and key company profiles
        • CMIC Holdings Co., Ltd.
        • Axxelus
        • EPS Holdings, Inc.
        • MaBico
        • IQVIA, Inc.
        • Peak Pharma
        • QFR Solutions
        • Promoveo Health
        • Syneous Health Inc.
        • Report Coverage
          Report Coverage

          Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

          Segment Covered
          Segment Covered

          This text is related
          to segments covered.

          Regional Scope
          Regional Scope

          North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

          Country Scope
          Country Scope

          This text is related
          to country scope.

          Frequently Asked Questions


          What are pharmaceutical contract sales organizations?

          Pharmaceutical companies may outsource their sales and marketing functions to third parties, commonly referred to as contract sales organizations, under the pharmaceutical contract sales outsourcing (CSO) business model. Because of the financial benefits, the improved flexibility, and the easy access to specialized knowledge, this practice has gained popularity in the pharmaceutical sector. Companies that manage contract sales teams also offer training, hiring, and performance evaluation. Contract sales outsourcing does, however, come with some drawbacks, including the potential loss of sales process control and the requirement to uphold solid vendor relationships.

          What are the driving factors for the pharmaceutical contract sales organizations market?

          Key factors driving the market growth are the increasing integration of digital technologies and the growing interest of pharmaceutical companies to increase sales of products. However, quality issues associated with outsourcing hinder the pharmaceutical contract sales organizations market growth.

          What are the growth estimates for the pharmaceutical contract sales organizations market till 2030?

          The pharmaceutical contract sales organizations market is expected to be valued at US$ 15,820.86 million in 2030.

          Who are the major players in the pharmaceutical contract sales organizations market?

          The pharmaceutical contract sales organizations market majorly consists of the players, including CMIC Holdings Co. Ltd.; Axxelus; EPS Holdings, Inc.; MaBico, IQVIA, Inc.; Peak PharmA; QFR Solutions; Promoveo Health; Syneous Health Inc.; and Mednext Pharmaceuticals Pvt. Ltd;.

          Which segment is dominating the pharmaceutical contract sales organizations market?

          The pharmaceutical contract sales organizations market: by service, is segmented into commercial services and non-commercial services. In 2022, the commercial services segment held the largest share of the market and is expected to grow at the fastest rate during the coming years. Commercial services refer to the range of services provided by contract sales organizations (CSOs) to pharmaceutical companies to support their sales and marketing efforts. CSOs are third-party organizations specializing in delivering sales and marketing services on behalf of pharmaceutical companies.

          What was the estimated pharmaceutical contract sales organizations market size in 2022?

          The pharmaceutical contract sales organizations market was valued at US$ 8,212.02 million in 2022.

          The List of Companies - Pharmaceutical Contract Sales Organizations Market

          1. CMIC Holdings Co., Ltd.
          2. Axxelus
          3. EPS Holdings, Inc. 
          4. MaBico
          5. IQVIA, Inc.
          6. Peak Pharma
          7. QFR Solutions
          8. Promoveo Health
          9. Syneous Health Inc.
          10. Mednext Pharmaceuticals Pvt. Ltd

          The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

          1. Data Collection and Secondary Research:

          As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

          Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

          1. Primary Research:

          The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

          For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

          A typical research interview fulfils the following functions:

          • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
          • Validates and strengthens in-house secondary research findings
          • Develops the analysis team’s expertise and market understanding

          Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

          • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
          • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

          Below is the breakup of our primary respondents by company, designation, and region:

          Research Methodology

          Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

          1. Data Analysis:

          Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

          • Macro-Economic Factor Analysis:

          We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

          • Country Level Data:

          Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

          • Company Profile:

          The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

          • Developing Base Number:

          Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

          1. Data Triangulation and Final Review:

          The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

          We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

          We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

          Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

          Related Reports